Interference with the expression of POSTN can inhibit the proliferation, migration, and invasion of RCC cells, and inhibit EMT through the ILK/AKT/mTOR signaling pathway (Jia Y. Y. et al., 2021). Here, AKT1 is linked to renal cell carcinoma.